Supriya Lifescience Ltd

  • BSE Code : 543434
  • NSE Symbol : SUPRIYA
  • ISIN : INE07RO01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 726.20 37.35(5.42%)

Open Price ()

688.85

Prev. Close ()

688.85

Volume (No’s)

1,786,377

Market Cap ()

5,844.66

Low Price ()

683.00

High Price ()

733.30

 

Book Closure

From Date To Date Announcement
24-Sep-2025 NA AGM 24/09/2025 Enclosed herewith is the Notice convening the 17th Annual General Meeting of Members of the Company scheduled to be held on Wednesday, September 24, 2025 at 3.00 pm. through Video Conferencing ('VC')/ Other Audio Video Means ('OAVM').
05-Sep-2025 NA Rs.1.0000 per share(50%)FinalDividend
04-Sep-2025 NA 50% Final Dividend
13-Aug-2025 NA Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday August 13 2025 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2025. This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2025 till 48 hours after declaration of Unaudited Financial Results on August 13 2025. Kindly take the above information on your records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday, August 13, 2025, inter-alia considered and approved the following: 1. Unaudited Financial Results: The Unaudited Financial Results for the Quarter ended June 30, 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 2015. 2. Approved revision/change in the following Policy/Code: ? Nomination and Remuneration Policy. ? Policy on Determination of Materiality of Events ? Code of Conduct to Regulate, Monitor and Report on Trading in Securities by Insiders. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 04.10 p.m. Kindly take the above information on your records. (As Per BSE Announcement Dated on: 13.08.2025)
27-May-2025 NA Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday May 27 2025 inter alia to: 1. Consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2025. 2. Recommend dividend if any on the Equity Shares of the Company for the financial year ended March 31 2025. This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2025 till 48 hours after declaration of Audited Financial Results on May 27 2025. Kindly take the above information on your records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Tuesday, May 27, 2025, inter-alia considered and approved the following: 1. Audited Financial Results 2. Dividend 3. Appointment of Secretarial Auditors The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 04.10 p.m. Kindly take the above information on your records. (As Per BSE Announcement Dated :27.05.2025)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew